Academy of Physicians
in Clinical Research

Academy of Physicians
in Clinical Research

News from SCRIP

APCR Members can get a free trial to SCRIP and a discount on a SCRIP subscription by contacting John Lezcano from SCRIP directly at the information below. 

John Lezcano
Corporate Account Manager

Pharma intelligence | informa
T: (212) 652-2678
M: (631) 807-4971

Pharma Wakes Up To Transformative Progress In Hearing Loss Research

Wed, 12/12/2018 - 5:32am

The cacophony of noise in the modern world is one factor driving the loss of hearing throughout humankind, a condition...

      Related Stories 

The Harsh Light Of Hard Facts: Valuing Pharma In A Made For Measure World

Wed, 12/12/2018 - 2:42am

With a challenging new decade of scientific discovery looming, 2019 is the positioning year for biopharma to make value, transparency...

      Related Stories 

Executives On The Move: New Hires at Omeros and Theratechnologies Plus Promotions at Alimera and Constellation

Wed, 12/12/2018 - 1:16am

Omeros gains a new head of commercial and a VP of CMC from Celgene, while Alimera Sciences promotes its president to CEO and Constellation Pharma moves...

      Related Stories 

Pilots Between NHS And Pharma Finally Take Off

Wed, 12/12/2018 - 12:47am

The majority of pharmaceutical companies in the UK work closely with the NHS and In Vivo spoke to one of them –...

      Related Stories 

Japan Pharma Climbing Aboard Digital Health Train, But Not Up To Speed?

Tue, 12/11/2018 - 8:51pm

The still somewhat loosely defined concept of 'digital health' continues to take concrete forms through recent deals in Japan, where...

      Related Stories 

Samsung BioLogics Vows Improved Management Transparency As Stock Resumes Trade

Tue, 12/11/2018 - 4:34pm

Following an exchange decision that Samsung BioLogics should remain listed, the company has vowed to improve management transparency by beefing...

      Related Stories 

The Medicines Co.’s Change Names Mark Timney As CEO In A Shakeup

Tue, 12/11/2018 - 1:15pm

CEO Clive Meanwell helped to shape the company over his nearly 22 years at the helm, including when it marketed...

      Related Stories 

Eisai Adds To Alzheimer's Arsenal With Anti-Tau Drug

Tue, 12/11/2018 - 8:26am

It is a field littered with failures but Eisai remains hopeful that its pipeline of candidates for Alzheimer's disease, which...

      Related Stories 

Data, Data, Everywhere, But How Much Of It Makes A Real Difference?

Tue, 12/11/2018 - 3:55am

Having a single patient's complete health care information all in one place was a dream that US visionaries began to...

      Related Stories 

Lessons From A Life Sciences Lifetime: An Interview With Sir John Bell

Mon, 12/10/2018 - 11:54pm

Professor Sir John Bell talks to In Vivo about how the life sciences sector has evolved during his career, lessons he has...

      Related Stories 

Pipeline Watch: Phase III Starts With Elacestrant, Crizanlizumab And Vutrisiran

Mon, 12/10/2018 - 11:20pm

Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events announced by pharmaceutical and biotech companies at medical...

      Related Stories 

Axovant Closes Chapter On Failed, Second-Rate Small Molecule Strategy

Mon, 12/10/2018 - 3:35pm

Termination of nelotanserin, a small molecule licensed from Arena, in Lewy body dementias comes after a dramatic shift toward gene...

      Related Stories